Ilypsa
Biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
$420m (Public information from Jun 2007)
Santa Clara United States (HQ)
Authorizing premium user...